Literature DB >> 18196475

The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage.

Rajat Dhar1, Michael N Diringer.   

Abstract

INTRODUCTION: Subarachnoid hemorrhage (SAH) can trigger immune activation sufficient to induce the systemic inflammatory response syndrome (SIRS). This may promote both extra-cerebral organ dysfunction and delayed cerebral ischemia, contributing to worse outcome. We ascertained the frequency and predictors of SIRS after spontaneous SAH, and determined whether degree of early systemic inflammation predicted the occurrence of vasospasm and clinical outcome.
METHODS: Retrospective analysis of prospectively collected data on 276 consecutive patients admitted to a neurosciences intensive care unit with acute, non-traumatic SAH between 2002 and 2005. A daily SIRS score was derived by summing the number of variables meeting standard criteria (HR >90, RR >20, Temperature >38 degrees C, or <36 degrees C, WBC count <4,000 or >12,000). SIRS was considered present if two or more criteria were met, while SIRS burden over the first four days was calculated by averaging daily scores. Regression modeling was used to determine the relationship among SIRS burden (after controlling for confounders including infection, surgery, and corticosteroid use), symptomatic vasospasm, and outcome, determined by hospital disposition.
RESULTS: SIRS was present in over half the patients on admission and developed in 85% within the first four days. Factors associated with SIRS included poor clinical grade, thick cisternal blood, larger aneurysm size, higher admission blood pressure, and surgery for aneurysm clipping. Higher SIRS burden was independently associated with death or discharge to nursing home (OR 2.20/point, 95% CI 1.27-3.81). All of those developing clinical vasospasm had evidence of SIRS, with greater SIRS burden predicting increased risk for delayed ischemic neurological deficits (OR 1.77/point, 95% CI 1.12-2.80).
CONCLUSIONS: Systemic inflammatory activation is common after SAH even in the absence of infection; it is more frequent in those with more severe hemorrhage and in those who undergo surgical clipping. Higher burden of SIRS in the initial four days independently predicts symptomatic vasospasm and is associated with worse outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18196475      PMCID: PMC2538678          DOI: 10.1007/s12028-008-9054-2

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  46 in total

Review 1.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

2.  A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies.

Authors:  G M Teasdale; C G Drake; W Hunt; N Kassell; K Sano; B Pertuiset; J C De Villiers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

3.  Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Gruber; A Reinprecht; U M Illievich; R Fitzgerald; W Dietrich; T Czech; B Richling
Journal:  Crit Care Med       Date:  1999-03       Impact factor: 7.598

4.  Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.

Authors:  M Bavbek; R Polin; A L Kwan; A S Arthur; N F Kassell; K S Lee
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

5.  Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage.

Authors:  E Oconnor; B Venkatesh; C Mashongonyika; J Lipman; J Hall; P Thomas
Journal:  Anaesth Intensive Care       Date:  2004-08       Impact factor: 1.669

6.  Immunological reaction against the aging human subarachnoid erythrocyte. A model for the onset of cerebral vasospasm after subarachnoid hemorrhage.

Authors:  J W Peterson; B D Kwun; A Teramura; J D Hackett; J A Morgan; S Nishizawa; T Bun; N T Zervas
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

7.  Beta-blockade benefits patients following a subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; P Walter; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone.

Authors:  D Chyatte
Journal:  Stroke       Date:  1989-08       Impact factor: 7.914

9.  Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm.

Authors:  B Weir; L Disney; M Grace; P Roberts
Journal:  Neurosurgery       Date:  1989-08       Impact factor: 4.654

10.  Cerebral blood flow is reduced in patients with sepsis syndrome.

Authors:  D L Bowton; N H Bertels; D S Prough; D A Stump
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

View more
  67 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  RAR-Related Orphan Receptor Gamma T (RoRγt)-Related Cytokines Play a Role in Neutrophil Infiltration of the Central Nervous System After Subarachnoid Hemorrhage.

Authors:  A P Coulibaly; W T Gartman; V Swank; J A Gomes; L Ruozhuo; J DeBacker; J J Provencio
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

3.  Subarachnoid hemorrhage-associated arachnoiditis and syringomyelia.

Authors:  J Eneling; S Boström; S Rossitti
Journal:  Clin Neuroradiol       Date:  2011-06-18       Impact factor: 3.649

4.  The Association Between Spontaneous Hyperventilation, Delayed Cerebral Ischemia, and Poor Neurological Outcome in Patients with Subarachnoid Hemorrhage.

Authors:  Craig A Williamson; Kyle M Sheehan; Renuka Tipirneni; Christopher D Roark; Aditya S Pandey; B Gregory Thompson; Venkatakrishna Rajajee
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

5.  Systemic Inflammatory Response Syndrome and Outcomes in Intracerebral Hemorrhage.

Authors:  Amelia K Boehme; Angela N Hays; Kimberly P Kicielinski; Kanika Arora; Niren Kapoor; Michael J Lyerly; Alissa Gadpaille; Harn Shiue; Karen Albright; David Miller; Mitchell S V Elkind; Mark R Harrigan
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

6.  Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Authors:  Alan K H Tam; Don Ilodigwe; Jay Mocco; Stephan Mayer; Neal Kassell; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

7.  Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Michael Crimmins; Hector Lantigua; Andres Fernandez; Chris Zammit; Cristina Falo; Sachin Agarwal; Jan Claassen; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

8.  Factors associated with the development of anemia after subarachnoid hemorrhage.

Authors:  Tomoko R Sampson; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

9.  CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage.

Authors:  J J Provencio; X Fu; A Siu; P A Rasmussen; S L Hazen; R M Ransohoff
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

10.  TNF-alpha and sICAM-1 in intracranial aneurismal rupture.

Authors:  Anna Maria Witkowska; Maria Halina Borawska; Katarzyna Socha; Jan Kochanowicz; Zenon Mariak; Maria Konopka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-04-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.